IRIS ZINK: Open Payments
NPI 1487729752 · EAST LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,094 in 229 payments from 21 companies in 2025. Trend: 2023 $5,755 · 2024 $6,913 · 2025 $7,094
Food & beverage: $5,719Consulting: $1,320Education: $55
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 19 | $1,936 |
| Janssen Biotech, Inc. | 48 | $1,310 |
| Amgen Inc. | 29 | $719 |
| ABBVIE INC. | 43 | $696 |
| UCB, Inc. | 23 | $607 |
| Novartis Pharmaceuticals Corporation | 18 | $464 |
| AstraZeneca Pharmaceuticals LP | 15 | $384 |
| Alexion Pharmaceuticals, Inc. | 2 | $177 |
| Organon LLC | 6 | $131 |
| LEO Pharma Inc. | 2 | $122 |
Products named: TREMFYA, RINVOQ, ORENCIA, Bimzelx, COSENTYX, SAPHNELO, TAVNEOS, HADLIMA.
Industry payments across MI — which companies pay providers there.
